MSAM
CRL icon

Moloney Securities Asset Management’s Charles River Laboratories CRL Stock Holding History

Moloney Securities Asset Management’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-3,548
Closed -$383K – 276
2017
Q3 		$383K Buy
+3,548
New +$365K 0.17% 159

Other funds holding CRL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $100B AUM 36.93% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Moloney Securities Asset Management's CRL Position: Q4 2017 in Review

Moloney Securities Asset Management sold out of Charles River Laboratories (CRL) in Q4 2017, closing a stake of 3,548 shares — an estimated $383K sold.

Moloney Securities Asset Management first reported a position in CRL in Q3 2017 and held it in 1 quarter. The position peaked at $383K in Q3 2017. 339 funds tracked by Wall St. Rank hold CRL as of Q4 2017.

  • Moloney Securities Asset Management reported no remaining Charles River Laboratories position as of Q4 2017 after selling out during the quarter.
  • Moloney Securities Asset Management sold 3,548 Charles River Laboratories shares in Q4 2017, an estimated $383K.
  • Moloney Securities Asset Management first reported a position in Charles River Laboratories in Q3 2017 and held it in 1 quarter.
  • Moloney Securities Asset Management's Charles River Laboratories position peaked at $383K in Q3 2017.
  • 339 funds tracked by Wall St. Rank held Charles River Laboratories as of Q4 2017.

Based on Moloney Securities Asset Management's 13F filing for Q4 2017, filed 25 Jan 2018.